Clinical characteristics and short-term outcomes of acute pancreatitis among patients with COVID-19

J Zhang, D Luo, M Kang, B Li, S Su - European Journal of Medical …, 2023 - Springer
Objective The existing literature on the combination of acute pancreatitis (AP) and COVID-19
is scarce. The objective of our study is to compare the clinical outcomes and occurrence of …

Population-based clinical studies using routinely collected data in Hong Kong, China: a systematic review of trends and established local practices

D Wu, RHK Nam, KSK Leung, H Waraich… - Cardiovascular …, 2023 - scienceopen.com
Background: Routinely collected health data are increasingly used in clinical research. No
study has systematically reviewed the temporal trends in the number of publications and …

Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post …

Z Sezer, STI Pavel, A Inal, H Yetiskin, B Kaplan… - Vaccines, 2024 - mdpi.com
Vaccine-induced immunity wanes over time and warrants booster doses. We investigated
the long-term (32 weeks) immunogenicity and safety of a third, homologous, open-label …

[HTML][HTML] Population-Based Evaluation of Vaccine Effectiveness against SARS-CoV-2 Infection, Severe Illness, and Death, Taiwan

CY Lee, HW Kuo, YL Liu, JH Chuang… - Emerging Infectious …, 2024 - ncbi.nlm.nih.gov
Taiwan provided several COVID-19 vaccine platforms: mRNA (BNT162b2, mRNA-1273),
adenoviral vector-based (AZD1222), and protein subunit (MVC-COV1901). After Taiwan …

Association of Demographic, Clinical, and Vaccination Characteristics with COVID-19 Viral Load Assessed by qRT-PCR

M Khorraminejad-Shirazi, SS Nabavizadeh… - Archives of Iranian …, 2023 - journalaim.com
Background: The effect of vaccination on the SARS-CoV-2 baseline viral load and clearance
during COVID-19 infection is debatable. This study aimed to assess the effects of …

Effectiveness and Respiratory Adverse Events Following Inactivated and mRNA COVID-19 Vaccines in Patients with COPD and Asthma: A Chinese Population-Based …

SX Qin, FWT Cheng, WC Kwok, LWY Fung, TT Ma… - Drug Safety, 2024 - Springer
Introduction Effectiveness and respiratory adverse events following coronavirus disease-
2019 (COVID-19) vaccines have not been well investigated in Chinese patients with chronic …

Elevated risk of multimorbidity post-COVID-19 infection: protective effect of vaccination

FTT Lai, W Liu, Y Hu, C Wei, RYK Chu… - … Journal of Medicine, 2024 - academic.oup.com
Background It is unclear how the coronavirus disease 2019 (Covid-19) pandemic has
affected multimorbidity incidence among those with one pre-existing chronic condition, as …

Safety and immunogenicity of COReNAPCIN®, a SARS-CoV-2 mRNA vaccine; a randomized, double-blind, placebo-controlled phase 1 clinical trial

M Salehi, IA Darazam, A Nematollahi… - medRxiv, 2023 - medrxiv.org
The repeated COVID-19 outbreaks, despite global vaccination, highlights the need for
booster doses. Here, we present the outcomes, up until day 90 post vaccination, of a …

Population-Based Clinical Studies Using Routinely Collected Data in Hong Kong: A Systematic Review of Established Local Practices and Counterfactual Analysis

D Wu, R Nam, KSK Leung, H Waraich, AF Purnomo… - 2023 - papers.ssrn.com
Background: Routinely collected health data are increasingly used for clinical or
epidemiological research. However, no study has systematically reviewed the temporal …

Clinical Characteristics and Short-term Outcomes of Acute Pancreatitis with COVID-19

J Zhang, B Li, S Su - 2023 - researchsquare.com
Materials and methods This retrospective, observational study was conducted at a single
center. It included patients aged 18 years and above who were diagnosed with AP during …